France Warns Of Serious Complications Related To OTC Ibuprofen Use
Executive Summary
French medicines regulator ANSM warns that use of certain OTC NSAIDs increases the risk of serious complications when suffering from a minor infection. The agency is advising consumers not to use iburofen or ketoprofen to treat pain or fever, and to instead opt for paracetamol.
You may also be interested in...
EU Warns Flurbiprofen Can Potentially Mask Infection Symptoms
Popular OTC sore throat treatment flurbiprofen can possibly mask the symptoms of infection and lead to treatment delays, according to EU medicines regulators. Products sold in the EU containing flurbiprofen will soon be required to carry information warning patients and healthcare professionals about this risk.
EMA Committee Warns Ibuprofen Can Seriously Exacerbate Infections
EMA's Pharmacovigilance Risk Assessment Committee wants ibuprofen and ketoprofen products to carry new warnings related to the risk of exacerbating serious infections.
‘Insufficient Evidence’ Ibuprofen Worsens COVID-19, Says UK Regulator
Review by MHRA advisory body finds no issue with ibuprofen use in COVID-19 patients and updates advice to recommend either paracetamol or ibuprofen to treat symptoms.